A. Jooya MD

Dr. Alborz Jooya

MD.CM, MSc, FRCPC, DABR

Affiliations

Radiation Oncologist

Arthur J.E. Child Comprehensive Cancer Centre

Assistant Professor

Cumming School of Medicine, Department of Oncology

Member

Arnie Charbonneau Cancer Institute

Contact information

Preferred method of communication

Admin Assistant: 

Background

Credentials

MDCM, McGill University,

MSc, McGill University,

FRCPC - Radiation Oncology, The Ottawa Hospital, University of Ottawa,

MRL Fellowship, Princess Margaret Hospital, Toronto, ON,

Biography

Dr. Alborz Jooya is a radiation oncologist at the Arthur J.E. Child Comprehensive Cancer Centre, and Assistant Professor in the Department of Oncology at the University of Calgary. He completed his medical degree (MDCM) and Master of Science (MSc) in Experimental Medicine at McGill University, followed by radiation oncology residency training (FRCPC) at The Ottawa Hospital, University of Ottawa. Dr. Jooya then completed a joint fellowship in MR-Linac (MRL) and GI malignancies at Princess Margaret Hospital in Toronto, Ontario. 

His clinical practice focuses on treatment of breast and genitourinary malignancies and he is actively involved in related clinical trials. His research interests include MR-Linac based SBRT treatments, and medical education in adaptive workflows.

Clinical leadership: Dr. Jooya is the SBRT Site Group Lead and the Genitourinary MRL Program Lead.

Medical education leadership: Dr. Jooya is the Clinical Curriculum Lead for the Radiation Oncology Residency Program and a member of the Residency Program Competency Committee.

Research

Areas of Research

Area of Focus
  • Ultra-hypofractionated SBRT using MR Linac system
  • SBRT for renal cell carcinoma (RCC)
  • Combining SBRT and radioligand therapy for oligometastatic cancers
  • MR based imaging biomarkers and radiomics with use of artificial intelligence (AI) and machine learning
  • Clinical trials for breast cancer patients
Summary of Research

Dr. Jooya’s research focuses on stereotactic body radiotherapy (SBRT) for genitourinary (GU) and oligometastatic cancers, including treatments delivered on the MR-Linac (MRL) system. He is also actively involved in breast cancer clinical trials. He is Principal Investigator on several clinical trials and leads a number of ongoing and planned trials and projects within the department.

In medical education, Dr. Jooya is leading a research training program in supporting the transition to therapist-driven adaptive SBRT workflows on the MR-Linac.